About Us
Established in 1998, went public in May 2012, Dongcheng Biochemicals Co.,Ltd has developed into an enterprise group which combines ……
NEWS
Dongcheng Pharmaceutical has continuously increased its investment in scientific research and is committed to independent innovation.
Products
Dongcheng Pharmaceutical has continuously increased its investment in scientific research and is committed to independent innovation.
Branch
China's radiopharmaceutical industry is still in its infancy. In 2013, the output value of radio medicines nationwide was 2 billion yuan,
Service and Support
DCB now is one of the biggest biochemical API manufacturers in China, With leading production technology, reliable product quality and excellent international qualification background,
Investor Relations
Care for life with sincerity, Continuous innovation, striving for perfection! In the future, DCB will carry on the mission of serving human health,
Established in February 2010, Dongcheng Biochemicals (USA) Inc., wholly owned subsidiary of Dongcheng Biochemicals, is located in LA USA. Totally invested in 1.2million, this company focuses on local sales development of nutritional health care products raw materials and pharmaceutical raw materials such as Heparin Sodium and Chondroitin Sulfate etc.
With warehouse in LA USA, Dongcheng Biochemicals (USA) Inc. is responsible for not only customs clearance、storage and delivery but also keeping tight connection with customers and providing excellent service to satisfy customers and increase sales. Through join in American CPHI、visit new customers and collect marketing information, Dongcheng Biochemicals (USA) Inc. continuously reclaim new customers and sales channel, which has laid a solid foundation for sales increasing in the future.
During operation, the company strictly abides by the American laws, keep close contact with local embassy in China and make great efforts for ensuring the safety of company and personnel.
